Table 1

Pharmacokinetic parameters for stavudine after i.v. administration in various laboratory animals (N = 3–5)

SpeciesDoseMean (S.D.) Pharmacokinetic Parameter Value1-a
T1/2CLCLRCLNRVssUR
(mg/kg) (h) (ml/min/kg) (ml/min/kg) (ml/min/kg) (l/kg) (%)
Mouse1-b 250.3028.7NDND0.76ND
Rat500.43  (0.06)24.0  (2.73)1-e 19.1  (2.75)1-f 4.86  (1.24)0.70  (0.08)1-h 79.2  (5.4)
1500.56  (0.13)16.0  (2.93)1-e 11.6  (2.47)4.45  (0.66)0.51  (0.10)71.9  (4.0)
6001.02  (0.38)1-d 10.0  (0.92)1-e 8.31  (1.51)1.69  (1.12)1-g 0.50  (0.05)83.1  (11.8)
Rabbit1-c 100.85  (0.10)23.4  (3.6)8.82  (3.9)ND1.12  (0.13)36.0  (8.0)
Monkey12.50.74  (0.06)14.5  (2.2)NDND0.92  (0.07)ND
500.76  (0.05)14.2  (4.7)NDND0.92  (0.23)ND
2000.91  (0.18)10.7  (1.5)NDND0.83  (0.05)ND
  • 1-a T1/2, terminal half-life; CL, total body clearance; CLR, renal clearance; CLNR, nonrenal clearance; Vss, steady state volume of distribution; UR, urinary recovery of unchanged drug; ND, not determined.

  • 1-b Data from reference Russell et al., 1990, using a composite curve, N = 3 animals/time point.

  • 1-c Data from reference Wong and Swachuk, 1991.

  • 1-d Statistically different from the 50 and 150 mg/kg dose groups, p < .05.

  • 1-e Statistically different between dose groups, p < .05.

  • 1-f Statistically different from the 150 and 600 mg/kg dose groups, p < .05.

  • 1-g Statistically different from the 50 and 150 mg/kg dose groups, p < .05.

  • 1-h Statistically different from the 150 and 600 mg/kg dose groups, p < .05.